Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism.

adrenal venous sampling adrenalectomy lateralization index norcholesterol adrenal scintigraphy primary aldosteronism

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
07 Jul 2023
Historique:
received: 12 06 2023
revised: 05 07 2023
accepted: 05 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

To evaluate the diagnostic accuracy of the 131I-6β-iodomethyl-19-norcholesterol (NP-59) adrenal scintigraphy for the subtyping diagnosis of primary aldosteronism (PA), considering as gold standard for the diagnosis of unilateral PA (UPA), either the results of the adrenal venous sampling (AVS) or the outcome after adrenalectomy. A retrospective multicenter study was performed on PA patients from 14 Spanish tertiary hospitals who underwent NP-59 scintigraphy with an available subtyping diagnosis. Patients were classified as UPA if biochemical cure was achieved after adrenalectomy or/and if an AVS lateralization index > 4 with ACTH stimulation or >2 without ACTH stimulation was observed. Patients were classified as having bilateral PA (BPA) if the AVS lateralization index was ≤4 with ACTH or ≤2 without ACTH stimulation or if there was evidence of bilateral adrenal nodules >1 cm in each adrenal gland detected by CT/MRI. A total of 86 patients with PA were included (70.9% (n = 61) with UPA and 29.1% (n = 25) with BPA). Based on the NP-59 scintigraphy results, 16 patients showed normal suppressed adrenal gland uptake, and in the other 70 cases, PA was considered unilateral in 49 patients (70%) and bilateral in 21 (30%). Based on 59-scintigraphy results, 10.4% of the patients with unilateral uptake had BPA, and 27.3% of the cases with bilateral uptake had UPA. The AUC of the ROC curve of the NP-59 scintigraphy for PA subtyping was 0.812 [0.707-0.916]. Based on the results of the CT/MRI and NP-59 scintigraphy, only 6.7% of the patients with unilateral uptake had BPA, and 24% of the cases with bilateral uptake had UPA. The AUC of the ROC curve of the model combining CT/MRI and 59-scintigraphy results for subtyping PA was 0.869 [0.782-0.957]. The results of NP-59 scintigraphy in association with the information provided by the CT/MRI may be useful for PA subtyping. However, their diagnostic accuracy is only moderate. Therefore, it should be considered a second-line diagnostic tool when AVS is not an option.

Identifiants

pubmed: 37509573
pii: biomedicines11071934
doi: 10.3390/biomedicines11071934
pmc: PMC10377416
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Endocrine. 2022 Nov;78(2):363-372
pubmed: 35751774
Am J Hypertens. 2010 Dec;23(12):1253-60
pubmed: 20706195
J Renin Angiotensin Aldosterone Syst. 2021 Jan-Dec;22(1):14703203211003781
pubmed: 33752505
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
Ann Intern Med. 2009 Sep 1;151(5):329-37
pubmed: 19721021
Langenbecks Arch Surg. 2017 Mar;402(2):303-308
pubmed: 28224279
Eur J Radiol. 2020 Dec;133:109397
pubmed: 33190101
Endocrine. 2022 Jun;76(3):687-696
pubmed: 35275344
Med Clin (Barc). 2020 Oct 9;155(7):302-308
pubmed: 32586668
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699
pubmed: 28576687
Eur J Endocrinol. 2022 Nov 22;187(6):S47-S58
pubmed: 36315466
J Clin Endocrinol Metab. 2020 Jun 1;105(6):
pubmed: 31536622
J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300
pubmed: 17161262
J Clin Endocrinol Metab. 2012 Jan;97(1):100-9
pubmed: 22112805
Korean J Intern Med. 2014 Mar;29(2):217-25
pubmed: 24648805
J Nucl Med. 1985 Jan;26(1):43-8
pubmed: 2981301
Nucl Med Commun. 2019 Jun;40(6):568-575
pubmed: 30694876
Hypertension. 2019 Aug;74(2):368-374
pubmed: 31230553
J Clin Endocrinol Metab. 1990 Oct;71(4):825-30
pubmed: 2401712
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1400-e1407
pubmed: 33031550
J Biomed Biotechnol. 2011;2011:209787
pubmed: 21541242
Endocr J. 2011;58(9):711-21
pubmed: 21828936
J Hypertens. 2022 Dec 1;40(12):2486-2493
pubmed: 36018220
Ann Intern Med. 1979 Mar;90(3):386-95
pubmed: 218482
Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):150-6
pubmed: 25871964
Ann Nucl Med. 2023 Feb;37(2):89-98
pubmed: 36380175
J Nucl Med. 1990 Apr;31(4):526-34
pubmed: 2324830
Hypertension. 2011 May;57(5):990-5
pubmed: 21383311
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
World J Surg. 1997 Jan;21(1):36-40
pubmed: 8943175
J Clin Endocrinol Metab. 2014 Aug;99(8):2712-9
pubmed: 24796926
Nucl Med Commun. 2020 Dec;41(12):1226-1233
pubmed: 32956247
J Nucl Med. 2009 Oct;50(10):1631-7
pubmed: 19759122
J Formos Med Assoc. 2017 Dec;116(12):993-1005
pubmed: 28735660

Auteurs

Marta Araujo-Castro (M)

Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), 28034 Madrid, Spain.
Medicine Department, University of Alcalá, 28801 Madrid, Spain.

Miguel Paja Fano (M)

Endocrinology & Nutrition Department, OSI Bilbao-Basurto, Hospital Universitario de Basurto, 48013 Bilbao, Spain.
Medicine Department, Basque Country University, 48013 Bilbao, Spain.

Marga González Boillos (M)

Endocrinology & Nutrition Department, Hospital Universitario de Castellón, 12004 Castellón, Spain.

Eider Pascual-Corrales (E)

Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), 28034 Madrid, Spain.

Ana María García Cano (AM)

Biochemistry Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

Paola Parra Ramírez (P)

Endocrinology & Nutrition Department, Hospital Universitario La Paz, 28046 Madrid, Spain.

Patricia Martín Rojas-Marcos (P)

Endocrinology & Nutrition Department, Hospital Universitario La Paz, 28046 Madrid, Spain.

Almudena Vicente Delgado (A)

Endocrinology & Nutrition Department, Hospital Universitario de Toledo, 45007 Toledo, Spain.

Anna Casteràs (A)

Endocrinology & Nutrition Department, Hospital Universitario de Vall Hebron, 08035 Barcelona, Spain.

Albert Puig (A)

Endocrinology & Nutrition Department, Hospital Universitario de Vall Hebron, 08035 Barcelona, Spain.

Iñigo García Sanz (I)

General & Digestive Surgery Department, Hospital Universitario de La Princesa, 28006 Madrid, Spain.

Patricia Díaz Guardiola (P)

Endocrinology & Nutrition Department, Hospital Universitario Infanta Sofía, 28702 Madrid, Spain.

Cristina Robles Lázaro (C)

Endocrinology & Nutrition Department, Complejo Universitario de Salamanca, 37007 Salamanca, Spain.

Miguel Antonio Sampedro Núñez (MAS)

Endocrinology & Nutrition Department, Hospital Universitario La Princesa, 28006 Madrid, Spain.

Raquel Guerrero-Vázquez (R)

Endocrinology & Nutrition Department, Hospital Virgen de la Macarena, 41009 Sevilla, Spain.

María Del Castillo Tous (M)

Endocrinology & Nutrition Department, Hospital Virgen de la Macarena, 41009 Sevilla, Spain.

Theodora Michalopoulou Alevras (T)

Endocrinology & Nutrition Department, Hospital Joan XXIII, 43005 Tarragona, Spain.

Susana Tenes Rodrigo (S)

Internal Medicine, Hospital Infanta Leonor de Vallecas, 28031 Madrid, Spain.

Felicia A Hanzu (FA)

Endocrinology & Nutrition Department, Hospital Clinic, IDIPAS, 08007 Barcelona, Spain.

Classifications MeSH